Adc Therapeutics (ADCT) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for Adc Therapeutics (ADCT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | 20M (-33.50%) | 30M (+91.24%) | 16M (-12.94%) | 18M (+3.97%) | 17M (-3.01%) | 18M (-0.44%) | 18M (+5.81%) | 17M (-4.59%) | 18M (+7.27%) | 17M (+16.61%) | 14M (-25.68%) | 19M (+1.32%) | 19M |
Cost Of Revenue | - | 5.80M | - | - | - | 5.95M | - | - | - | 2.53M | - | - | - |
Costof Goods And Services Sold | - | 5.80M | - | - | - | 5.95M | - | - | - | 2.53M | - | - | - |
Gross Profit | - | 76M | - | - | - | 65M | - | - | - | 67M | - | - | - |
Operating Expenses | |||||||||||||
Research And Development | 20M (+9.35%) | 18M (-32.16%) | 27M (-10.93%) | 30M (+4.01%) | 29M (+6.75%) | 27M (-16.62%) | 33M (+33.74%) | 24M (-5.59%) | 26M (-15.13%) | 30M (+12.00%) | 27M (-13.59%) | 31M (-18.34%) | 38M |
Selling General And Administrative | 9.90M (+4.65%) | 9.46M (+13.57%) | 8.33M (-5.56%) | 8.82M (-11.45%) | 9.96M (+3.53%) | 9.62M (-3.80%) | 10M (-2.34%) | 10M (-14.88%) | 12M (+6.46%) | 11M (+17.46%) | 9.62M (-19.83%) | 12M (-22.58%) | 16M |
Operating Expenses | 46M (+12.49%) | 41M (-13.54%) | 47M (-24.75%) | 63M (+22.31%) | 52M (+4.36%) | 49M (-8.66%) | 54M (+16.32%) | 46M (-10.10%) | 52M (-8.98%) | 57M (+12.11%) | 51M (-14.07%) | 59M (-14.84%) | 69M |
Depreciation And Amortization | - | - | - | 360K (+5.88%) | 340K (0.00%) | 340K (0.00%) | 340K (+3.03%) | 330K (0.00%) | 330K (-2.94%) | 340K (+6.25%) | 320K (+18.52%) | 270K (+3.85%) | 260K |
Operating Income | |||||||||||||
Operating Income | -25.24M (+40.85%) | -17.92M (-42.14%) | -30.97M (-29.85%) | -44.15M (+55.13%) | -28.46M (-12.27%) | -32.44M (-8.77%) | -35.56M (+22.45%) | -29.04M (-13.60%) | -33.61M (-15.93%) | -39.98M (+10.59%) | -36.15M (-8.83%) | -39.65M (-21.03%) | -50.21M |
Ebit | -25.24M (+40.85%) | -17.92M (-42.14%) | -30.97M (-29.85%) | -44.15M (+55.13%) | -28.46M (-12.27%) | -32.44M (-8.77%) | -35.56M (+22.45%) | -29.04M (-13.60%) | -33.61M (-15.93%) | -39.98M (+10.59%) | -36.15M (-8.83%) | -39.65M (-21.03%) | -50.21M |
EBITDA | -20.62M (+15.07%) | -17.92M (-42.14%) | -30.97M (-29.26%) | -43.78M (+55.69%) | -28.12M (-12.37%) | -32.09M (-8.91%) | -35.23M (+22.71%) | -28.71M (-13.73%) | -33.28M (-16.04%) | -39.64M (+10.63%) | -35.83M (-9.01%) | -39.38M (-21.16%) | -49.95M |
Other Income / Expenses | |||||||||||||
Interest Income | 1.99M (-15.32%) | 2.35M (-4.86%) | 2.47M (+27.98%) | 1.93M (-5.85%) | 2.05M (-22.05%) | 2.63M (-23.55%) | 3.44M (+5.85%) | 3.25M (+10.17%) | 2.95M (-10.33%) | 3.29M (+21.85%) | 2.70M (+13.92%) | 2.37M (+9.22%) | 2.17M |
Interest Expense | 12M | -22.34M | 13M (+3.00%) | 13M (+6.30%) | 12M (+2.60%) | 12M (-9.15%) | 13M (+3.47%) | 13M (+1.44%) | 13M (-3.18%) | 13M (+0.70%) | 13M (+24.35%) | 10M (+0.19%) | 10M |
Net Interest Income | 1.99M (-86.35%) | 15M (+490.28%) | 2.47M (+27.98%) | 1.93M | -10.18M (+9.58%) | -9.29M (-4.03%) | -9.68M (+2.65%) | -9.43M (-1.26%) | -9.55M (-0.73%) | -9.62M (-4.85%) | -10.11M (+27.33%) | -7.94M (-2.22%) | -8.12M |
Other Non Operating Income | 2.63M (-88.42%) | 23M (+2341.94%) | 930K | -180.00K | 200K (-98.39%) | 12M (+669.14%) | 1.62M (-41.09%) | 2.75M | -2.59M | 6.35M (+638.37%) | 860K | -5.07M | 830K |
Net Income | |||||||||||||
Income Before Tax | -32.97M | 38M | - | - | -38.44M | - | - | - | - | - | - | - | - |
Income Tax Expense | - | -400.00K | - | 1.25M (+635.29%) | 170K | -320.00K | 90K (-60.87%) | 230K (+43.75%) | 160K (-99.63%) | 43M | -80.00K (-98.22%) | -4.50M | 520K |
Net Income From Continuing Operations | -32.97M (+414.35%) | -6.41M (-84.35%) | -40.97M (-27.68%) | -56.65M (+46.76%) | -38.60M (+25.61%) | -30.73M (-30.11%) | -43.97M (+20.33%) | -36.54M (-21.60%) | -46.61M (-45.18%) | -85.03M (+81.96%) | -46.73M (-4.48%) | -48.92M (-17.60%) | -59.37M |
Net Income | -32.97M (+414.35%) | -6.41M (-84.35%) | -40.97M (-27.68%) | -56.65M (+46.76%) | -38.60M (+25.61%) | -30.73M (-30.11%) | -43.97M (+20.33%) | -36.54M (-21.60%) | -46.61M (-45.18%) | -85.03M (+81.96%) | -46.73M (-4.48%) | -48.92M (-17.60%) | -59.37M |
Comprehensive Income Net Of Tax | -33.25M (-76.54%) | -141.72M (+243.31%) | -41.28M (-26.21%) | -55.94M (+46.17%) | -38.27M (-75.96%) | -159.18M (+266.52%) | -43.43M (+18.40%) | -36.68M (-21.47%) | -46.71M (-80.70%) | -241.97M (+415.05%) | -46.98M (-4.59%) | -49.24M (-17.29%) | -59.53M |